Publications by authors named "Pierre Falardeau"

Claim this Profile
T
TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.
Paul M Campbell, Nadia Boufaied, James J Fiordalisi, Adrienne D Cox, Pierre Falardeau

J Mol Signal· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation.
Nadia Boufaied, My-Anh Wioland, Pierre Falardeau, Henriette Gourdeau

Anticancer Drugs· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLN-05220, TLN-05223, new Echinosporamicin-type antibiotics, and proposed revision of the structure of bravomicins(*).
Arjun H Banskota, Mustapha Aouidate, Dan Sørensen, Ashraf Ibrahim, Mahmood Piraee, Pierre Falardeau

J Antibiot (Tokyo)· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
Henriette Gourdeau, James B McAlpine, Maxime Ranger, Bryan Simard, Francois Berger, Pierre Falardeau

Cancer Chemother Pharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.
Jean Latreille, Gerald Batist, Francis Laberge, Pierre Champagne, Daniel Croteau, Pierre Falardeau

Clin Lung Cancer· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue.
Eric Dupont, Pierre Falardeau, Shaker A Mousa, Violetta Dimitriadou, Marie-Claude Pepin

Clin Exp Metastasis· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Richard Béliveau, Denis Gingras, Erwin A Kruger, Sylvie Lamy, Pierre Sirois, Pierre Falardeau

Clin Cancer Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis